Although there are effective treatments for gout, the most common form of inflammatory arthritis, a new Arthritis Care & Research study found that opioids are commonly prescribed to patients with gout who seek treatment at emergency departments.
Although there are effective treatments for gout, the most common form of inflammatory arthritis, a new Arthritis Care & Research study found that opioids are commonly prescribed to patients with gout who seek treatment at emergency departments.
In the study of 456 patients with acute gout discharged from emergency departments in Rhode Island, more than 28% received an opioid prescription. Of these, more than one-quarter of patients received 14 days or more of opioid prescriptions, longer than the natural course of a typical gout attack. Diabetes, gout attacks affecting multiple joints, and opioid use prior to admission were associated with an increased likelihood of receiving opioid prescriptions.
“We have a number of medications that can treat acute gout effectively, almost completely eliminating the need to use opioids. The fact that 28% of patients are being treated with opioids, and many longer than 2 weeks, is alarming and provides an opportunity to reduce the burden of prescription opioids,” said co–lead author Deepan Dalal, MD, MPH, of Brown University Warren Alpert School of Medicine, in Providence.
Additional Information
Link to Study: https://onlinelibrary.wiley.com/doi/10.1002/acr.23928
About Journal
Arthritis Care & Research, an official journal of the American College of Rheumatology and the Association of Rheumatology Health Professionals (a division of the College), is a peer-reviewed publication that publishes original research, review articles, and editorials that promote excellence in the clinical practice of rheumatology. Relevant to the care of individuals with rheumatic diseases, major topics are evidence-based practice studies, clinical problems, practice guidelines, educational, social, and public health issues, health economics, health care policy, and future trends in rheumatology practice.
About Wiley
Wiley drives the world forward with research and education. Our scientific, technical, medical, and scholarly journals and our digital learning, certification, and student-lifecycle services and solutions help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company's website can be accessed at www.wiley.com.
Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com